
Nucleus Capital is a venture capital firm that focuses on deep-tech for planetary resilience, investing in pre-seed and seed-stage companies. Their strategy targets programmable biology (synthetic biology and techbio), food technology, and neo-industrials, often backing scientific founders in Europe and the US.
38% of their portfolio is in Food & Agriculture. Their most common stage is pre-seed (54% of deals). Average disclosed round size is $5.7M (across 13 rounds with reported amounts).
Portfolio
13
Fund Size
$40M
Top Stage
Pre Seed
Last 12 Mo
3
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
13 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| IIntactis Bio Corp | Pre-Seed | $250K | Mar 2026 |
| Series A | $8.8M | Jan 2026 | |
| SScience Machine | Pre-Seed | $2.9M | Jul 2025 |
| SSpark e-Fuels | Pre-Seed | $2.3M | Feb 2025 |
| Pre-Seed | $2.6M | Oct 2024 | |
| Seed | $6.8M | Sep 2024 | |
| Series A | $15.4M | Feb 2024 | |
| Series A | $15.4M | Dec 2023 | |
| Pre-Seed | $1.2M | May 2023 | |
| Pre-Seed | $2.6M | Jul 2022 | |
| Seed | $6M | Oct 2021 | |
| EEndolith | Seed | $5.1M | — |
| TTelura | Pre-Seed | $5M | — |
Top Co-Investors
World Fund3 shared
Cherry Ventures3 shared
IBB2 shared
Omnes Capital2 shared
Mudcake2 shared
EQT Ventures2 shared
Revent2 shared
Possible Ventures2 shared
Project A Ventures1 shared
Carbon Removal Partners1 shared
Zero Carbon Capital1 shared
Collaborative Fund1 shared
Overture1 shared
Grok Ventures1 shared
Embark Ventures1 shared
Bee Partners1 shared
FTW Ventures1 shared
Courtyard Ventures1 shared
Triple Point Ventures1 shared
HackCapital1 shared
Last updated: 12 April 2026